Upgrade to SI Premium - Free Trial

Oppenheimer Keeps Perform Rating on Oracle (ORCL): 'a step-up in Capex expense to support the RPO growth is consuming all the free cash flow generation'

September 10, 2025 6:32 AM
Oppenheimer analyst Brian Schwartz reiterated a Perform rating on Oracle (NYSE: ORCL).The analyst comments "Oracle's business got off to a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments

Next Articles